<DOC>
	<DOCNO>NCT01440725</DOCNO>
	<brief_summary>This multicenter , simple blind , mask outcome assessor , parallel , randomise clinical trial patient muscle rupture hematoma production . The main hypothesis infiltration area muscle injury autologous platelet-rich plasma ( PRP ) improve muscle regeneration repair shortening time complete recovery . The main objective evaluate PRP heal muscular lesion 'tennis leg ' type distal rectus femoral . The secondary objective : evaluate risk lesion recurrence ; evaluate quality lesion recovery process evaluate intervention 's safety . Experimental treatment administration PRP autologous ( 4-8 cc unique dose ) muscular infiltration en empty space generate hematoma evacuation . Control treatment hematoma evacuation . Both treatment group use compressive bandage recommend rest , extremity elevation , local ice lately physiotherapy . Size sample : 76 patient ( 38 group )</brief_summary>
	<brief_title>Efficacy Platelet Rich Plasma Treatment Muscle Rupture With Haematoma</brief_title>
	<detailed_description />
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Hematoma</mesh_term>
	<criteria>Adults 18 year Lesion haematoma Gastrocnemius muscle low portion rectus femoral muscle Acceptance participate clinical trial Not indicated surgical treatment muscle injury Exclusion criterion Patients meet inclusion criterion History bleed disorder Inability followup patient The use corticosteroid , acetylsalicylic acid ( Aspirin Â® ) nonsteroidal antiinflammatory drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>muscle</keyword>
	<keyword>injury</keyword>
	<keyword>platelet-rich plasma</keyword>
	<keyword>autologous</keyword>
	<keyword>haematoma</keyword>
</DOC>